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Abstract. The deployment of biomedical applications in a grid environment 
has started about three years ago in several European projects and national ini-
tiatives. These applications have demonstrated that the grid paradigm was rele-
vant to the needs of the biomedical community. They have also highlighted that 
this community had very specific requirements on middleware and needed fur-
ther structuring in large collaborations in order to participate to the deployment 
of grid infrastructures in the coming years. In this paper, we propose several ar-
eas where grid technology can today improve research and healthcare. A cru-
cial issue is to maximize the cross fertilization among projects in the perspec-
tive of an environment where data of medical interest can be stored and made 
easily available to the different actors of healthcare, the physicians, the health-
care centres and administrations, and of course the citizens.  
1   Introduction 
Last summer, about 10000 elderly people died in one European country because of 
unusually long and severe hot weather. For two weeks, the overall increase of mortal-
ity rate in hospitals and healthcare centres remained unnoticed. To better handle this 
kind of situation, a strategy is to set up a monitoring service recording daily on a cen-
tral repository the number of casualties in each healthcare centre. With the present 
telemedicine tools, such a monitoring service requires an operator in each healthcare 
centre to submit the information to the central repository and an operator to validate 
the information provided. In case of emergency, for instance if the monitoring service 
identifies an abnormal increase of the mortality rate, experts have to be called to ana-
lyze the information available at the central repository. If they want additional infor-
mation, they need to require it from the operators in each healthcare centre. This extra 
request may introduce major delays and extra work on health professionals who are 
already overworked.  
With the onset of grid technology, such a monitoring service would require much less 
manpower. Indeed, grid technology delivers today access in a secure way to data 
stored on distant grid nodes. Instead of having one operator in each centre in charge 
of transmitting information daily to the central repository, the information on the 
number of casualties is stored locally on a database which is accessible by the central 
repository. In case of emergency, the experts can access further to the healthcare cen-
tre database to inquire about the patient medical files. In this scenario, patient medical 
files stay in healthcare centres and the central monitoring service picks up only what 
is needed for its task.  
2 Vision for a grid for health 
The example used to introduce this paper illustrates the potential impact of grid tech-
nology for health. The grid technology is identified as one of the key technologies to 
enable the European research Area. Its impact is expected to reach much beyond 
eScience to eBusiness, eGouvernment, … and eHealth. However, a major challenge 
is to take the technology out of the laboratory to the citizen. A HealthGrid (figure 1) 
is an environment where data of medical interest can be stored and made easily avail-
able to the different actors of healthcare, the physicians, the healthcare centres and 
administrations, and of course the citizens. Such an environment has to offer all guar-
antees in terms of security, respect of ethics and regulations. Moreover, the associa-
tion of post-genomics and medical data on such an environment opens the perspective 
of individualized healthcare.   
While considering the deployment of life sciences applications, most present grid 
projects do not address the specificities of an e-infrastructure for health, for instance 
the deployment of grid nodes in clinical centres and in healthcare administrations, the 
connection of individual physicians to the grid and the strict regulations ruling the 
access to personal data,….  
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Fig. 1. Pictorial representation of the Healthgrid concept 
 
 
Technology to address these requirements in a grid environment is under develop-
ment and a pioneering work is under way in the application of Grid technologies to 
the health area. 
 
In the last couple of years, several grid projects have been funded on health related 
issues at national and European levels. These projects have a limited lifetime, from 3 
to 5 years, and a crucial issue is to maximize their cross fertilization. Indeed, the 
Healthgrid is a long term vision that needs to build on the contribution of all projects. 
The Healthgrid initiative, represented by the Healthgrid association 
(http://www.healthgrid.org), was initiated to bring the necessary long term continuity. 
Its goal is to collaborate with projects on the following activities:  
• Identification of potential business models for medical Grid applications; 
• Feedback to the Grid-development community on the requirements of the pi-
lot applications deployed by the European projects; 
• Dialogue with clinicians and people involved in medical research and Grid 
development to determine potential pilots; 
• Interaction with clinicians and researchers to gain feedback from the pilots; 
• Interaction with all relevant parties concerning legal and ethical issues  iden-
tified by the pilots; 
• Dissemination to the wider biomedical community on the outcome of the pi-
lots; 
• Interaction and exchange of results with similar groups worldwide; 
• Definition of potential new applications in conjunction with the end user 
communities. 
3 Requirements 
To deploy the monitoring service described in introduction to this article, patient 
medical data have to be stored in a local database in each healthcare centre. These 
databases have to be federated and must be interoperable. Secure access to data is 
mandatory: only views of local data should be available to external services and pa-
tient data should be anonymized when nominative information is not needed.  
These requirements have to be fed back to the community developing middleware 
services. The Healthgrid initiative is actively involved in the definition of require-
ments relevant to the usage of grids for health. As an example of a first list of re-
quirements, the one produced by DataGrid can be given.  
  
3.1 Data related requirements 
• Provide access to biology and medical image data from various existing da-
tabases  
• Support and improve existing databases import/export facilities 
• Provide transparent access to data from the user point of view, without 
knowledge of their actual location 
• Update databases while applications are still running on their own data ver-
sions  
3.2 Security related requirements 
• Grant anonymous and private login for access to public and private data-
bases 
• Guarantee the privacy of medical information  
• Provide an encryption of sensitive message  
• Fulfill all legal requirements in terms of  data encryption and protection of 
patient privacy  
• Enforce security policies without the need to modify applications 
 
3.3 Administration requirements 
• Provide "Virtual Grids", ie the ability to define subgrids with a restricted ac-
cess to data and computing power  
• Provide "Virtual Grids" with customizable login policies 
3.4 Network requirements 
• Provide batch computing on huge dataset 
• Provide fast processing applications which transfer small set of images be-
tween different sites : storage site, processing site and physician site 
• Provide interactive access to small data sets, like image slices and model ge-
ometry 
3.5 Job related requirements 
• Allow the user to run jobs "transparently", without the knowledge of the un-
derlying scheduling mechanism and resource availability  
• Manage jobs priorities  
• Deal with critical jobs : if no resource are available, jobs with lowest priority 
will be interrupted to allow execution of critical jobs  
• Permit to chain batch jobs into pipelines  
• Provide a fault-tolerant infrastructure with fault detection, logging and re-
covery   
• Notify an user when a job fails for a Grid independent reason  
• Provide an interactive mode for some applications  
• Support for parallel jobs  
• Provide a message passing  interface  inside a local farm and also at the Grid 
level  
• Offer Job monitoring and control, i.e. query job status, cancel queuing or 
running job  
• Provide logs to understand system failures and intruders detection. 
 
4   DataGrid 
The deployment of biomedical applications in a grid environment has started about 
three years ago in several European projects and national initiatives. These applica-
tions have demonstrated that the grid paradigm was relevant to the needs of the bio-
medical community.  
The European DataGrid (EDG) project [1], which started three years ago, success-
fully concluded on 31 March 2004. It aimed at taking a major step towards making 
the concept of a world-wide computing Grid a reality. The goal of EDG was to build 
a test computing infrastructure capable of providing shared data and computing re-
sources across the European scientific community. The budget for the project was 
around 10 million euros and 21 partner institutes and organizations across Europe 
were involved.  
After a massive development effort involving seven major software releases over 
three years, the final version of EDG software is already in use in three major scien-
tific fields: High Energy Physics, Biomedical applications and Earth Observations. At 
peak performance, the EDG test bed shared more than 1000 processors and more than 
15 Terabytes of disk space spread in 25 sites across Europe, Russia and Taïwan. The 
software is exploited by several bio-medical applications in the area of bioinformatics 
and biomedical simulation. 
4.1   Monte-Carlo simulation for nuclear medicine and radio/brachytherapy 
The principle of Monte-Carlo simulations is to reproduce radiation transport know-
ing the probability distributions governing each interaction of particles in the patient 
body and in the different equipments needed in nuclear medicine and 
brachy/radiotherapy: gamma-camera and PET for nuclear medicine, accelerator head 
for radiotherapy and internal radiation applicators for brachytherapy. Accuracy is 
therefore only limited by the number of particles generated. As a consequence, 
Monte-Carlo simulations are increasingly used in nuclear medicine to generate simu-
lated PET and SPECT images to assess the performances of reconstruction algorithms 
in terms of resolution, sensitivity and quantification and to design innovative detec-
tors. In external beam radiotherapy, Monte-Carlo simulations are needed for accelera-
tor head modelling and computation of beam phase space [2]. Accelerator beam mod-
elling is especially critical to reach high accuracy in gradient and shielded regions for 
Intensity Modulated Radiation Therapy. Measurement of dose deposit by applicators 
in brachytherapy is often difficult experimentally because of high gradient. In the 
case of electron sources, Monte-Carlo simulation is especially relevant provided elec-
tron transport is properly described.    
All in all, the major limiting factor for the clinical implementation of Monte-Carlo 
dose calculations methods is the large computing time requested to reach the desired 
accuracy. Most of the commercial systems, named TPS (Treatment Planning Sys-
tems), for clinical routine use an analytic calculation to determine dose distributions 
and so, errors near heterogeneities in the patient can reach 10 to 20%. Such codes are 
very fast comparing to Monte Carlo simulations: the TPS computation time for an 
ocular brachytherapy treatment is lower than on minute, thus allowing its usage in 
clinical practice, while a Monte Carlo framework could take 2 hours.  
To evaluate the impact of parallel and distributed Monte Carlo simulations, a radio-
therapy treatment planning was performed on the EDG Testbed, from pre-processing 
and registration of medical images on the Storage Elements (SEs) of the grid to the 
parallel computation of Monte Carlo simulations GATE (Geant4 Application for To-
mographic Emission [3]. 
The application framework is depicted in figure 3. Sets of 40 DICOM slices or so, 
5122 pixels each, acquired by CT scanners are concatenated and stored in a 3D image  
format. Such image files can reach until 20 MB for our application. To solve privacy 
issues, DICOM headers are wiped out in this process. 
             
 
Fig. 2. GATE Monte Carlo simulations: a) PET simulation; b) Radiotherapy simu-
lation; c) Ocular brachytherapy simulation 
 
The 3D image files are then registered and replicated on the sites of the EDG testbed 
where GATE is installed in order to compute simulations (5 sites to date). During the 
computation of the GATE simulation, the images are read by GATE and interpreted 
in order to produce a 3D array of voxels whose value is describing a body tissue. A 
relational database is used to link the GUID of image files with metadata extracted 
from the DICOM slices on the patient and additional medical information. The EDG 
Spitfire software is used to provide access to the relational databases. 
 
          
 
Fig. 3.  Submission of GATE jobs on the DataGrid testbed 
 
Every Monte Carlo simulation is based on the generation of pseudorandom numbers 
using a Random Numbers Generator (RNG). An obvious way to parallelize the calcu-
lations on multiple processors is to partition a sequence of random numbers generated 
by the RNG into suitable independent sub-sequences. 
To perform this step, the choice has been done to use the Sequence Splitting Method 
[4],[5]. For each sub-sequences, we save in a file (some KBs) the current status of the 
random engine. Each simulation is then launched on the grid with the 
status file. All the other files necessary to run Gate on the grid are automatically cre-
ated: the script describing the environment of computation, the macros GATE de-
scribing the simulations, the status files of the RNG and the job description files. 
 
In order to show the advantage for the GATE simulations to partition the calculation 
on multiple processors, the simulations were split and executed in parallel on several 
grid nodes. Table 1 illustrates the computing time in minutes of a GATE simulation 
running on a single P4 processor at 1.5GHz locally and the same simulation splitting 
by 10, 20, 50 and 100 jobs on multiple processors [6]. 
 
Table 1. Sequential versus grid computation time using 10 to 100 nodes 
 
Number of jobs submitted 10 20 50 100 Local 
Total computing time in minutes 31 20,5 31 38 159 
 
The results show a significant improvement in computation time although the com-
puting time using Monte Carlo calculations should stay comparable to what it is cur-
rently with analytical calculations for clinical practice. The next challenge is to pro-
vide the necessary quality of service requested by the medical user to compute his 
simulation on the grid. 
4.2  Bioinformatics grid-enabled portals 
One of the current major challenges in the bioinformatics field is to derive valuable 
information from ongoing complete genome sequencing projects (currently 1087 ge-
nome projects with 182 published ones), which provide the bioinformatics commu-
nity with a large number of sequences. The analysis of such huge sets of genomic 
data requires big storage and computing capacities, accessible through user-friendly 
interfaces such as web portals. Today, the genomic and post-genomic web portals 
available rely on their local cpu and storage resources. 
 
 
 
Fig. 4: Bioinformatics algorithm schema 
 
Grid computing may be a viable solution to go beyond these limitations and to bring 
computing resources suitable to the genomic research field.  
A solution explored in the European DataGrid project was to interface the NPS@ 
web  
site [ref.] dedicated to protein structure analysis to the DataGrid infrastructure. 
 
The bioinformatics sequence algorithms used on NPS@ web portal are of different 
types depending on the data analyses they aim to compute: sequence homology and 
similarity searching (e.g. BLAST, FASTA), patterns and signatures searching (e.g. 
PattInProt), multiple alignment of proteins (e.g. ClustalW), secondary structure pre-
diction and so on. The “gridification” of web portals for genomics has to deal with 
these different algorithms and their associated models concerning their storage and 
CPU resources consumption (Figure 4). The bioinformatics algorithms for protein 
analysis can be classified into 4 categories on the criteria of CPU resources and in-
put/output data requirements (Table 2).  
According to its class, an algorithm is sent to the grid in a batch mode by distributing 
the algorithm and creating subsets of the input data or in a MPI-like (message passing 
interface) execution context by sending sub processes to different nodes of the grid 
(although this mode isn’t currently stable enough to be used in DataGrid).  
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Table 2. Classification of the bioinformatics algorithms used in GPS@ according to 
their data and CPU requirements. 
 
In fact, the major problem with a grid computing infrastructure is the distribution of 
the data and their synchronization according to the current release. Moving on the 
grid a databank which size varies from tens of megabytes (e.g. SwissProt) to giga-
bytes (e.g. EMBL), requires a significant fraction of the network bandwith and there-
fore increases the execution time. One simple solution can be to split databanks into 
subsets sent in parallel to several grid nodes, in order to run the same query on each 
subset. Such approach requires a synchronization of all the output files at the end. A 
more efficient solution would be to update the databanks on several referenced nodes 
with the help of the Replica Manager provided by the DataGrid middleware and to 
launch the selected algorithms on these nodes. To summarize, the algorithms working 
on short dataset are sent at runtime with the data through the grid sandbox while the 
ones  analyzing large datasets are executed on the grid nodes where the related data-
banks have been transported earlier by the DataGrid replica manager service. 
 
GPS@ - Grid Protein Sequence Analysis. Depending on the algorithms, DataGrid 
submission process is different. Some of the algorithms on NPS@ portal have been 
adapted in agreement to the DataGrid context, and will be made available to the bi-
ologist end-user in a real production web portal in the future (they can be tested on 
the  URL http://gpsa.ibcp.fr). GPS@ offers the same bioinformatics queries as 
NPS@, with the addition of job submission on DataGrid resources accessible through 
a drag-and-drop mechanism and simply pressing the “submit” button. All the Data-
Grid job management is encapsulated into the GPS@ backoffice: scheduling and 
 
Fig. 5: Bioinformatic job processing on GPS@ web portal 
status of the submitted jobs (Fig. 5). And finally the result of the biological grid jobs 
are displayed into a new web page, ready for further analysis or for download 
4.3. Humanitarian  medical development 
The training of local clinicians is the best way to raise the standard of medical knowl-
edge in developing countries. This requires transferring skills, techniques and re-
sources. Grid technologies open new perspectives for preparation and follow-up of 
medical missions in developing countries as well as support to local medical centres 
in terms of teleconsulting, telediagnosis, patient follow-up and e-learning. To meet 
requirements of a development project of the French NPO Chain of Hope in China, a 
first protocol was established for describing the patient pathologies and their pre- and 
post-surgery states through a web interface in a language-independent way. This pro-
tocol was evaluated by French and Chinese clinicians during medical missions in the 
fall 2003 [7]. The first sets of medical patients recorded in the databases will be used 
to evaluate grid implementation of services and to deploy a grid-based federation of 
databases. Such a federation of databases keeps medical data distributed in the hospi-
tals behind firewalls. Views of the data will be granted according to individual access 
rights through secured networks. 
 
 
 
 
 
Fig. 4.  Schematic representation of data storage architecture and information flow 
between three hospitals. 
4.4. Medical image storage, retrieval and processing 
Medical images represent tremendous amounts of data produced in healthcare centers 
each day. Picture Archiving and Communication Systems (PACS) are proposed by 
imager manufacturers to help hospitals archiving and managing their images. In addi-
tion to PACS, Radiological Information Systems (RIS) are deploy to store medical 
records of patients. PACS and RIS are developped with an clinical objective of us-
ability. However, they usually do not address the problems of large scale (cross-site) 
medical data exchange as most of them are proprietary manufacturers solution that do 
not rely on any existing standard for interoperability. Moreoever, they are usually 
weakly addressing the security problems arising in wide scale grid computing since 
they are usually bounded to each health center. Finally, they do not consider the in-
creasing need for automated data analysis and they do not offer any interface to ex-
ternal computing resources such as a grid. 
Grids are a logical extension of regional PACS and RIS. However, many technical 
issues as well as an adaptation of the medical world to Information Technology tools 
delay the wide applicability of grid technologies in this field. In the European Data-
Grid project and the French National MEDIGRID project [5], we have been working 
on medical data management and grid processing on medical data [6]. 
4.4.1 Medical data management 
In order to grid enable medical image processing application, it is necessary to inter-
face the hospitals medical information system with the grid. Figure 4 illustrates the 
Distribued Medical Data Manager (DM2) developped in the MEDIGRID project. The 
DM2 is an interface between the grid middleware and the medical server. On the hos-
pital side, it interfaces to Digital Image and COmmunication in Medicine (DICOM) 
servers. DICOM is the most widely accepted standard for medical images storage and 
communication. Most recent medical imagers are DICOM compliant: they produce 
images that they can locally archive or transfer to a DICOM server. The DM2 can be 
conneted to one central or several distributed DICOM servers available in the hospi-
tal. On the grid side, the DM2 provides a grid storage interface. Each time a medical 
image is recored on the DICOM server, the DM2 registers a new file entry on the grid 
data management system. It also contains a database storing metadata (the medical 
record) associated to images. From the grid side, images recorded are accessible to 
authorized users as any file regularly registered. The image can be accessed by a grid 
node through the DM2 interface which translates the grid incoming request into a 
DICOM request and returns the desired file. However, the DM2 provide additional 
services such as automatic data anonymization and encryption to prevent critical data 
from being accessible by non accredited users. See [8] for details. 
 
 
 
Fig. 5.  DM :  A Distributed Medical Data Manager 
 
4.4.2 Medical data processing 
Through an interface such as the DM2 a grid can offer an access to large medical 
image and metadata databases spread over different sites. This is usefull for many 
data intensive medical image processing applications for which large datasets are 
needed. Moreover, grids are well suited to handle computation resulting from explor-
ing full databases. For instance, epidemiology is a field requiring to collect statistics 
over large population of patients. For rare pathologies, this can only be achieved if 
data providing from a large number of sites can be assembled. Building digital atlases 
also requires to assemble large image sets. 
An example of a grid image content-based retrieval application is described in detail 
in [7] and depicted in figure 5. The typical scenario is a medical doctor diagnosing a 
medical image of one of his/her patient that has been previously registered (1,2). To 
confirm his/her diagnosis, he/she would like to confront it to similar known medical 
cases. The application allows the physician to search for recorded images similar to 
the source image he is interested in. Target candidates are first selected out of the 
database by querrying image metadata (3). Several similarity criterion may then be 
used to compare each image from the database to the source image. The similarity 
compuation algorithms return a score. Images of the database can be ranked accord-
ing to this score and the physician can download highest score images corresponding 
to most similar cases. This application requires one similarity job to be started for 
each candidate image to be compared in the database (4). These computations are 
distributed over available grid nodes to speed up the search (5,6). Given the absence 
of dependencies between the computations, the computing time is therefore divided 
by the number of processor available, neglecting the grid overhead (network trans-
mission of data and scheduling overhead). This application has been successfully 
deployed on the EDG testbed, processing up to hundreds of images (tens of images 
are processed in parallel). 
 
 
Fig. 6.  Application synopsis 
5. An emerging project: a grid to address a rare disease 
Another area where grid technology offers promising perspectives for health is drug 
discovery. This chapter presents the potential interest of a grid dedicated to Research 
and development on a rare disease.     
5.1 The crisis of neglected diseases 
There is presently a crisis in research and development for drugs for neglected dis-
eases. Infectious diseases kill 14 million people each year, more than ninety percent 
of whom are in the developing world. Access to treatment for these diseases is prob-
lematic because the medicines are unaffordable, some have become ineffective due to 
resistance, and others are not appropriately adapted to specific local conditions and 
constraints. Despite the enormous burden of disease, drug discovery and development 
targeted at infectious and parasitic diseases in poor countries has virtually ground to a 
standstill, so that these diseases are de facto neglected. Of the 1393 new drugs ap-
proved between 1975 and 1999, less than 1% (6) was specifically for tropical dis-
eases. Only a small percentage of global expenditure on health research and develop-
ment, estimated at US$50-60 billion annually, is devoted to the development of such 
medicines. At the same time, the efficiency of existing treatments has fallen, due 
mainly to emerging drug resistance. 
The unavailability of appropriate drugs to treat neglected diseases is among other 
factors a result of the lack of ongoing R&D into these diseases. While basic research 
often takes place in university or government labs, development is almost exclusively 
done by the pharmaceutical industry, and the most significant gap is in the translation 
of basic research through to drug development from the public to the private sector. 
Another critical point is the launching of clinical trials for promising candidate drugs.  
Producing more drugs for neglected diseases requires building a focussed, disease-
specific R&D agenda including short-, mid- and long-term projects. It requires also a 
public-private partnership through collaborations that aims at improving access to 
drugs and stimulating discovery of easy-to-use, affordable, effective drugs.  
 
5.2 The grid impact 
The grid should gather: 
1. drug designers to identify new drugs 
2. healthcare centres involved in clinical tests 
3. healthcare centres collecting patent information 
4. structures involved in distributing existing treatments (healthcare administra-
tions, non profit organizations,…) 
5. IT technology developers  
6. Computing centres 
7. Biomedical laboratories searching for vaccines, working on the genomes of 
the virus and/or the parasite and/or the parasite vector 
 
The grid will be used as a tool for:  
1. Search of new drug targets through post-genomics requiring data manage-
ment and computing 
2. massive docking to search for new drugs requiring high performance com-
puting and data storage 
3. handling of clinical tests and patent data  requiring data storage and man-
agement 
4. overseeing the distribution of the existing drugs requiring data storage and 
management 
 
A grid dedicated to research and development on a given disease should provide the 
following services:  
1. large computing resources for search for new targets and virtual docking 
2. large resources for storage of post genomics and virtual docking data output 
3. grid portal to access post genomics and virtual docking data 
4. grid portal to access medical information (clinical tests, drug distribution,…) 
5. a collaboration environment for the participating partners. No one entity can 
have an impact on all R&D aspects involved in addressing one disease. 
 
Such a project would build the core of a community pioneering the use of grid-
enabled medical applications. The choice of a neglected disease should help reducing 
the participants reluctance to share information. However, the issue of Intellectual 
Property must be addressed in thorough details.  
 
6. Conclusion 
The grid technology is identified as one of the key technologies to enable the Euro-
pean research Area. Its impact is expected to reach much beyond eScience to eBusi-
ness, eGouvernment, … and eHealth. However, a major challenge is to take the tech-
nology out of the laboratory to the citizen. A HealthGrid is an environment where 
data of medical interest can be stored and made easily available to the different actors 
of healthcare, the physicians, the healthcare centres and administrations, and of 
course the citizens. Such an environment has to offer all guarantees in terms of secu-
rity, respect of ethics and regulations. Moreover, the association of post-genomics 
and medical data on such an environment opens the perspective of individualized 
healthcare.  
 
The deployment of biomedical applications in a grid environment has started about 
three years ago in several European projects and national initiatives. These applica-
tions have demonstrated that the grid paradigm was relevant to the needs of the bio-
medical community.  
In this paper, we have reported on our experience in the deployment of biomedical 
grid applications within the framework of the DataGrid project.  
… 
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